Entry |
|
Symbol |
IKBKB
|
Name |
(RefSeq) inhibitor of nuclear factor kappa-B kinase subunit beta isoform X1
|
KO |
K07209 | inhibitor of nuclear factor kappa-B kinase subunit beta [EC:2.7.11.10] |
|
Organism |
nle Nomascus leucogenys (northern white-cheeked gibbon)
|
Pathway |
nle04620 | Toll-like receptor signaling pathway |
nle04621 | NOD-like receptor signaling pathway |
nle04622 | RIG-I-like receptor signaling pathway |
nle04625 | C-type lectin receptor signaling pathway |
nle04658 | Th1 and Th2 cell differentiation |
nle04660 | T cell receptor signaling pathway |
nle04662 | B cell receptor signaling pathway |
nle04920 | Adipocytokine signaling pathway |
nle04932 | Non-alcoholic fatty liver disease |
nle05163 | Human cytomegalovirus infection |
nle05166 | Human T-cell leukemia virus 1 infection |
nle05167 | Kaposi sarcoma-associated herpesvirus infection |
nle05168 | Herpes simplex virus 1 infection |
nle05170 | Human immunodeficiency virus 1 infection |
nle05208 | Chemical carcinogenesis - reactive oxygen species |
nle05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer |
nle05418 | Fluid shear stress and atherosclerosis |
|
Brite |
KEGG Orthology (KO) [BR:nle00001]
09130 Environmental Information Processing
09132 Signal transduction
04010 MAPK signaling pathway
100588081 (IKBKB)
04014 Ras signaling pathway
100588081 (IKBKB)
04064 NF-kappa B signaling pathway
100588081 (IKBKB)
04668 TNF signaling pathway
100588081 (IKBKB)
04068 FoxO signaling pathway
100588081 (IKBKB)
04151 PI3K-Akt signaling pathway
100588081 (IKBKB)
04150 mTOR signaling pathway
100588081 (IKBKB)
09140 Cellular Processes
09143 Cell growth and death
04210 Apoptosis
100588081 (IKBKB)
09150 Organismal Systems
09151 Immune system
04620 Toll-like receptor signaling pathway
100588081 (IKBKB)
04621 NOD-like receptor signaling pathway
100588081 (IKBKB)
04622 RIG-I-like receptor signaling pathway
100588081 (IKBKB)
04623 Cytosolic DNA-sensing pathway
100588081 (IKBKB)
04625 C-type lectin receptor signaling pathway
100588081 (IKBKB)
04660 T cell receptor signaling pathway
100588081 (IKBKB)
04658 Th1 and Th2 cell differentiation
100588081 (IKBKB)
04659 Th17 cell differentiation
100588081 (IKBKB)
04657 IL-17 signaling pathway
100588081 (IKBKB)
04662 B cell receptor signaling pathway
100588081 (IKBKB)
04062 Chemokine signaling pathway
100588081 (IKBKB)
09152 Endocrine system
04910 Insulin signaling pathway
100588081 (IKBKB)
04920 Adipocytokine signaling pathway
100588081 (IKBKB)
09156 Nervous system
04722 Neurotrophin signaling pathway
100588081 (IKBKB)
09158 Development and regeneration
04380 Osteoclast differentiation
100588081 (IKBKB)
09160 Human Diseases
09161 Cancer: overview
05200 Pathways in cancer
100588081 (IKBKB)
05206 MicroRNAs in cancer
100588081 (IKBKB)
05208 Chemical carcinogenesis - reactive oxygen species
100588081 (IKBKB)
05235 PD-L1 expression and PD-1 checkpoint pathway in cancer
100588081 (IKBKB)
09162 Cancer: specific types
05212 Pancreatic cancer
100588081 (IKBKB)
05221 Acute myeloid leukemia
100588081 (IKBKB)
05220 Chronic myeloid leukemia
100588081 (IKBKB)
05215 Prostate cancer
100588081 (IKBKB)
05222 Small cell lung cancer
100588081 (IKBKB)
09172 Infectious disease: viral
05166 Human T-cell leukemia virus 1 infection
100588081 (IKBKB)
05170 Human immunodeficiency virus 1 infection
100588081 (IKBKB)
05161 Hepatitis B
100588081 (IKBKB)
05160 Hepatitis C
100588081 (IKBKB)
05171 Coronavirus disease - COVID-19
100588081 (IKBKB)
05164 Influenza A
100588081 (IKBKB)
05162 Measles
100588081 (IKBKB)
05168 Herpes simplex virus 1 infection
100588081 (IKBKB)
05163 Human cytomegalovirus infection
100588081 (IKBKB)
05167 Kaposi sarcoma-associated herpesvirus infection
100588081 (IKBKB)
05169 Epstein-Barr virus infection
100588081 (IKBKB)
05165 Human papillomavirus infection
100588081 (IKBKB)
09171 Infectious disease: bacterial
05132 Salmonella infection
100588081 (IKBKB)
05135 Yersinia infection
100588081 (IKBKB)
09174 Infectious disease: parasitic
05145 Toxoplasmosis
100588081 (IKBKB)
05142 Chagas disease
100588081 (IKBKB)
09164 Neurodegenerative disease
05010 Alzheimer disease
100588081 (IKBKB)
09166 Cardiovascular disease
05417 Lipid and atherosclerosis
100588081 (IKBKB)
05418 Fluid shear stress and atherosclerosis
100588081 (IKBKB)
09167 Endocrine and metabolic disease
04930 Type II diabetes mellitus
100588081 (IKBKB)
04936 Alcoholic liver disease
100588081 (IKBKB)
04932 Non-alcoholic fatty liver disease
100588081 (IKBKB)
04931 Insulin resistance
100588081 (IKBKB)
09176 Drug resistance: antineoplastic
01523 Antifolate resistance
100588081 (IKBKB)
09180 Brite Hierarchies
09181 Protein families: metabolism
01001 Protein kinases [BR:nle01001]
100588081 (IKBKB)
Enzymes [BR:nle01000]
2. Transferases
2.7 Transferring phosphorus-containing groups
2.7.11 Protein-serine/threonine kinases
2.7.11.10 IkappaB kinase
100588081 (IKBKB)
Protein kinases [BR:nle01001]
Serine/threonine kinases: Other
IKK family [OT]
100588081 (IKBKB)
|
SSDB |
|
Motif |
|
Other DBs |
|
LinkDB |
|
Position |
8:46944440..47004889
|
AA seq |
756 aa
MSWSPSLTTQTCGAWEMKERLGTGGFGNVIRWHNQETGEQIAIKQCRQELSPRNRERWCL
EIQIMRRLTHPNVVAARDVPEGMQNLAPNDLPLLAMEYCQGGDLRKYLNQFENCCGLREG
AILTLLSDIASALRYLHENRIIHRDLKPENIVLQQGEQRLIHKIIDLGYAKELDQGSLCT
SFVGTLQYLAPELLEQQKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHSKVRQKSE
VDIVVSEDLNGTVKFSSSLPYPNNLNSVLAERLEKWLQLMLMWHPRQRGTDPTYGPNGCF
KALDDILNLKLVHILNMVTGTIHTYPVTEDESLQSLKARIQQDTGIPEEDQELLQEAGLA
LIPDKPATQCISDGKLNEGRTLDMDLVFLFDNSKITYETQISPRPQPESVSCILQEPKRN
LAFFQLRKVWGQVWHSIQTLKEDCNRLQQGQRAAMMNLLRNNSCLSKMKNSMASMSQQLK
AKLDFFKTSIQIDLEKYSEQTEFGITSDKLLLAWREMEQAVELCGRENEVKLLVERMMAL
QTDIVDLQRSPMGRKQGGTLDDLEEQARELYRRLREKPRDQRTEGDSQEMVRLLLQAIQS
FEKKVRVIYTQLSKTVVCKQKALELLPKVEEVVSLMNEDEKTVVRLQEKRQKELWNLLKI
ACSKVRGPVSGSPDSMNASRLSQPGQLMSQPSTASNSLPEPAKKSEELVAEAHNLCTLLE
NAIQDTVREQDQSFTALDWSWLQAEEEEHSCLEQTS |
NT seq |
2271 nt +upstreamnt +downstreamnt
atgagctggtcaccttccctgacaacgcagacatgtggggcctgggaaatgaaagagcgc
cttgggacagggggatttggaaatgtcatccgatggcacaatcaggaaacaggtgagcag
attgccatcaagcagtgccggcaggagctcagtccccggaaccgagagcggtggtgcctg
gagatccagatcatgagaaggctgacccaccccaatgtggtggctgcccgagatgtccct
gaggggatgcagaacttggcgcccaatgacctgcccctgctggccatggagtactgccaa
ggaggggatctccggaagtacctgaatcagtttgagaactgctgtggtctgcgggaaggc
gccatcctcaccttgctgagtgacattgcctctgcgcttagataccttcatgaaaacaga
atcatccatcgggatctaaagccagaaaacatcgtcctgcagcaaggagaacagaggtta
atacacaaaattattgacctaggatatgccaaggagctggatcagggcagtctttgcact
tcattcgtggggaccctgcagtacctggccccagagctactggagcagcagaagtacaca
gtgaccgtcgactactggagcttcggaaccctggcctttgagtgcatcacgggcttccgg
cccttcctccccaactggcagcccgtgcagtggcattcgaaagtgcggcagaagagtgag
gtggacattgttgttagcgaagacttgaatggaacagtgaagttttcaagctctttaccc
taccccaataatcttaacagcgtcctggctgagcgactggagaagtggctgcaactgatg
ttgatgtggcacccccgacagaggggcacggatcccacgtatgggcccaacggctgcttc
aaggccctggatgacatcttaaacttaaagctggttcatatcttgaacatggtcacgggc
accatccacacctaccctgtgacagaggatgagagtctgcagagcttgaaggccagaatc
cagcaggacacgggcatcccagaggaggaccaggagctgctgcaggaagcgggcctggcg
ttgatccccgataagcctgccactcagtgtatttcagacggcaagttaaatgagggccgc
acattggacatggatcttgtttttctctttgacaacagtaaaatcacctatgagactcag
atctccccacggccccaacctgaaagtgtcagctgtatccttcaagagcccaagaggaat
ctcgccttcttccagctgaggaaggtgtggggccaggtctggcatagcatccagaccctg
aaggaggattgcaaccggctgcagcagggacagcgagccgccatgatgaatctcctccga
aacaacagctgcctctccaagatgaagaattccatggcttccatgtctcagcagctcaag
gccaagttggatttcttcaaaaccagcatccagattgacctggagaagtacagcgagcaa
accgagtttgggatcacatcagataaactgctgctggcctggagggaaatggagcaggct
gtggagctctgtgggcgggagaacgaagtgaaactcctggtagaacggatgatggctctg
cagaccgacatcgtggacttacagaggagccccatgggccggaagcaggggggaacgctg
gacgacctagaggagcaagcaagggagctgtacaggagactaagggaaaaacctcgagac
cagcgaactgagggtgacagtcaggaaatggtacggctgctgcttcaggcaattcagagc
ttcgagaagaaagtgcgagtgatctatacgcagctcagtaaaactgtggtttgcaagcag
aaggcactagaactgttgcccaaggtggaagaggtggtgagcttaatgaatgaggatgag
aagactgttgtccggctgcaggagaagcggcagaaggagctctggaatctcctgaagatt
gcttgtagcaaggtccgtggtcctgtcagtggaagccccgatagcatgaacgcctctcga
cttagccagcctgggcagctgatgtctcagccctccacggcctccaacagcttacccgag
ccagccaagaagagtgaagaactggtggctgaagcacataacctctgcaccctgctagaa
aatgccatacaggacaccgtgagggaacaagaccagagtttcacggccctagactggagc
tggttacaggcggaagaagaagagcacagctgcctggagcagacctcatga |